key: cord-0861159-1d4glhx7 authors: Mansurian, M.; Ghandi, Y.; Habibi, D.; Mehrabi, S. title: COVID-19 infection in children: A systematic review and meta-analysis of clinical features and laboratory findings date: 2021-01-09 journal: Arch Pediatr DOI: 10.1016/j.arcped.2020.12.008 sha: 0bc7d0f30a8471b845fd0165b659b32eaf96d0e0 doc_id: 861159 cord_uid: 1d4glhx7 Objective: We aimed to provide a meta-analysis of previously published papers on the COVID-19-related clinical features and laboratory findings in children. Method: This meta-analysis was conducted by using Medline/PubMed, Scopus, Web of Sciences and Google Scholar. Finally, 32 articles were selected for full-text assessment. Results: The most frequent symptoms were fever, cough, vomiting, diarrhea, sore throat, and dyspnea. Regarding the combined results of the meta-analysis, fever (46%, 95% CI 40–53%), cough (37%, 95% CI 29–46%), diarrhea (19%, 95% CI 9–28%), and pharyngalgia (13%, 95% CI 5–20%) were the most widely reported symptom. Besides, positive RT-PCR test results (43%, 95% CI 33–53%), low oxygen saturation (38%, 95% CI 25–51%), and elevated D-dimer levels (36%, 95% CI 16–56%) were the most common laboratory findings. Conclusion: This review found that clinical presentations were milder, the prognosis was better, and the mortality rate was lower in children with COVID-19 compared with adult patients; however, children are potential carriers, like adults, and can transmit the infection among the population. Therefore, early identification and intervention in pediatric patients with COVID-19 are essential in order to control the pandemic. Moreover, gastrointestinal symptoms were more common symptoms among children. On December 31, 2019, an "unknown viral pneumonia" was first introduced in Wuhan, China. It was originally referred to as the "2019 coronavirus novel" [1, 2] . Children have always played a significant role in disease outbreaks and epidemics as they are potential carriers and spreaders [3] . On January 20, 2020, the first pediatric case of the novel coronavirus infection was confirmed in Shenzhen, China. [4] . About 20 days later, 398 confirmed pediatric cases and 10,924 adult cases of COVID-19 were reported in China; however, the number of infected children was not accurate because primary screening was not completely performed for them. In a study of 44,672 laboratory-confirmed cases in China, only 416 (0.9%) patients were younger than 10 years and 549 (1.2%) of them were between 10 and 20 years old [3, 5] . The first case of an infant with COVID-19 reported was a 3-month-old female infant, from Xiaogan, Hubei province, with fever, who was diagnosed on January 26 [6] . With the growing number of adult patients, the number of infected children increased as well. It was found that the virus was highly contagious as "second-generation" infections were reported [6] . According to a study of nine hospitalized infected infants, at least one of their family members had been infected [7] . Another study by Zhang et al. of an infected infant raised the question of whether the infection had a shorter incubation time in the infant or whether her parents acquired the infection from the baby [6] . However, all these children belonged to family cluster circles, and thus the onset of aggregation is an important feature in the children's cases, and this was a strong indication that the virus is highly contagious. The study by Cai et al. conducted with the first pediatric case outside Hubei province was the first study that suggested children as a source of infection in adults [8] . Children with COVID-19 can be asymptomatic or present with fever, dry cough, fatigue, and sometimes gastrointestinal symptoms, including abdominal discomfort, nausea, vomiting, abdominal pain, and diarrhea. They also showed mild symptoms with a good prognosis most of the time and recovered after 1-2 weeks [6, 9] ; however, there were severe pediatric cases that were also detected, such as the 1-year-old infant with severe COVID-19 ported by Chen et al. in Wuhan Children's Hospital [10] . A normal white blood cell count and absolute lymphocyte count in most pediatric cases suggests less immune dysfunction after the SARS-CoV-2 infection [6, 9] . It is suggested that mild infection in children is the result of trained immunity. This immunity is related to the use of particular vaccines such as the bacille Calmette-Guerin (BCG) vaccine, which train innate immunity to generate immune memory [5] . It has been proven that BCG provided nonspecific protection of mice against the influenza virus [11] . This vaccine has been given to most Asian children, and it J o u r n a l P r e -p r o o f is known that the influenza infection causes more severe respiratory symptoms in adults compared with children in these countries [11] . The clinical manifestations of COVID-19 have been unclear because the clinical and laboratory features of infected children were limited. This study is a meta-analysis of SARS-CoV-2 infection in children focusing on the clinical features and laboratory findings. This study aims to analyze the clinical characteristics of COVID-19 in children by summarizing the clinical and laboratory data reported in recent observational studies. This systematic review was conducted, using Medline/PubMed, Scopus, Web of Sciences, and Google Scholar, to identify studies published on COVID-19 following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [12] . The keywords used to search the studies were: "Novel coronavirus," "Novel coronavirus 2019", "2019 nCoV", "COVID-19", "Wuhan coronavirus," "Wuhan pneumonia," and "SARS-CoV-2," up to April 14, 2020 . The results were reviewed by two authors (conventional double-screening), the abstracts were screened, and related studies were selected. Finally, the full texts of the selected studies were reviewed and 32 publications were selected for the meta-analysis (Figure 1 ). Studies with incomplete information, review articles, opinions, and letters were excluded. The meta-analysis was performed using Stata software version 14 (StataCorp. 2015, Stata Statistical Software: Release 14, College Station, TX). Due to the nature of the studies, substantial heterogeneity was expected. Heterogeneity was assessed with the Q test and quantified numerically using the I 2 index [13] . For I 2 < 50%, i.e., non-heterogeneity, a fixed-effects model (DerSimonian-Laird method) was applied; otherwise, sensitivity analysis was used to find out the causes of heterogeneity, and if there was no clinical heterogeneity, a random-effects model was used with the estimate of heterogeneity being taken from an inverse-variance model (DerSimonian J o u r n a l P r e -p r o o f and Laird, 1986) [14] . Publication bias was evaluated by Egger's and Begg's tests at the 5% significant level [15] . Forest plots were used to visualize the prevalence in each study and the combined estimated prevalence with 95% confidence intervals (95% CI), with the size of each box indicating the weight of the study and each crossed line referring to the 95% CI. A total of 569 articles were initially retrieved and 32 articles were finally selected for full-text assessment. The main characteristics of the studies included are shown in Table 1 [7, . Out of the 32 publications, three were performed in Iran, the United States, and Spain and the other 29 studies were conducted by Chinese researchers. The total sample size consisted of 759 children, of whom 399 were male. Table 2 presents the clinical symptoms of COVID-19 in children. However, several clinical symptoms were reported in different studies; the most frequent symptoms were fever, cough, vomiting, diarrhea, sore throat, and dyspnea. The combined results of the meta-analysis based on clinical data are presented in Table 2 .The forest plots of the most common clinical symptoms are depicted in Figures 2 and 3 . Regarding the clinical manifestations, fever (46%, 95% CI 40-53%), cough (37%, 95% CI 29-46%), diarrhea (19%, 95% CI 9-28%), and pharyngalgia (13%, 95% CI 5-20%) were the most commonly reported symptom in children. The laboratory findings and the combined estimated prevalence with 95% confidence intervals (95% CI) are shown in Table 2 . Our results showed that positive RT-PCR test results (43%, 95% CI 33-53%), low oxygen saturation (38%, 95% CI 25-51%), and elevated D-dimer levels (36%, 95% CI 16-56%) were the most common laboratory findings in children. Since the use of funnel plots for assessment of potential publication bias is inaccurate in the metaanalysis of proportion studies [47] , we utilized significance tests to identify publication bias. For this purpose, Egger's and Begg's tests were used to assess publication bias. Since Begg's test is less powerful than Egger's test, we report the results of Egger's test. The adjusted trim and fill statistics are also demonstrated for studies with a high risk of publication bias in Table 2 . To assess and evaluate the quality of evidence, we used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) guidelines [48] . The quality of evidence was classified into four levels: "very low," "low," "moderate," or "high" judgment. If there was a dispute, it would be resolved by consensus or consultation. All studies were judged to be of high quality. The contagious disease COVID-19 can be transmitted from an asymptomatic infected person or an asymptomatic carrier by contact and respiratory droplets.. The incubation period can be up to 24 days. Most of the patients experience mild symptoms, but the elderly or those with underlying conditions are more likely to develop severe symptoms [28, 49] . The clinical manifestations in children as the same as in adults; however, children present with more gastrointestinal symptoms. In this systematic review and random-effects meta-analysis, we aimed to summarize the recently published clinical data of COVID-19 confirmed cases. We analyzed data on pediatric patients for major clinical manifestations and their associated significant laboratory findings. Our findings are robust in that we used a random-effects meta-analysis model. This involves an assumption that the effects being estimated in the different studies are not identical, but follow some distribution. For random-effects analyses, the pooled estimate and 95% CIs refer to the center of the distribution of pooled prevalence but do not describe the width of the distribution. Often the pooled estimate and its 95% CI are quoted in isolation as an alternative estimate of the quantity evaluated in a fixed-effect meta-analysis, which is inappropriate. Based on initial observation studies in China, patientsparticularly adult patientsprevalently presented with fever and cough, as well as dyspnea, and myalgia. Based on the analysis of all the included publications in this study, the same results were also found elsewhere. Han et al. reported that diarrhea and/or vomiting (gastrointestinal involvement) were the more common symptoms in infected children, and elevated creatine kinase isoenzyme levels (57.1%) and leukocyte counts (28.6%) were common laboratory findings too [49] . By contrast, this analysis indicated that fever and cough were the most frequent clinical manifestations of COVID-19 in children, and that leukopenia (22%) and leukocytosis (23%) were the most prevalent laboratory findings. In the study by Han et al., abnormal coagulation function, hypoalbuminemia, and hyperuricemias were reported in infected pediatric patients [49] . Moreover, elevated creatine kinase isoenzyme levels were detected by myocardial zymography in children. This may be explained by intense chills associated with high fever or by the higher incidence of myocardial damage in children. They also found elevated C-reactive protein (CRP) and D-dimer levels in 28.6% and 28.6% of the pediatric patients, respectively. Based on this analysis, positive CRP and positive D-dimer results were detected in 15% and 35% of the total sample, respectively. In a study by Su et al., elevated CK-MB levels were detected in six children with COVID-19, which suggests that SARS-CoV-2 may cause heart injury [39] since CK-MB is an indicator of myocardial injury. It is reported that the main mechanisms of SARS-CoV-2-induced myocardial injury may be the direct injury of the virus, of a cytokine storm, and the distribution of the ACE2 receptor. In the present study, the CK-MB level was found to be 30%. An increase in serum amyloid A, high-sensitivity CRP, lactate dehydrogenase, and αhydroxybutyrate dehydrogenase as well as a decrease in pre-albumin were detected in the majority of the cases [53] . Ultimately, being aware of the differences between the clinical presentations in children and adults is helpful for the clinical diagnosis and treatment approach of COVID-19 in children. It also helps to discuss the age-specific pattern of coronavirus infection more accurately. Our results show that more comprehensive clinical studies, including short-and long-term followup cohort assessments, are still required. It would also be beneficial to have more studies from other countries, as most available studies are currently from one country, i.e., China. To clarify the clinical spectrum of the disease, further clinical data are required. Currently, more regions, including the Americas and Europe, are struggling with the increasing number of infected cases and more studies from these areas would be extremely helpful. To date, regardless of the types of reports, the clinical findings were very similar. In the current pandemic, available data and evidence should constantly be evaluated to help This review has several limitations. Few studies were available and most of them were from China. It would be better to include studies with a broad geographic scope for a more comprehensive understanding of COVID-19. More detailed patient information, particularly regarding clinical outcomes, was unavailable in most studies at the time of the analyses; however, the data in this review offer an initial summary of the clinical and laboratory characteristics of COVID-19. This review study showed that clinical presentations were milder, the prognosis was better, and the mortality rate was lower in children with COVID-19 compared with adult patients; however, children are potential carriers, like adults, and can transmit the infection among the population. J o u r n a l P r e -p r o o f Therefore, early identification and intervention in pediatric patients with COVID-19 are essential to control the pandemic. Moreover, gastrointestinal symptoms were more common symptoms among children. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. World Health Organization. Coronavirus disease 2019, Outbreak, World Health Organization Coronavirus Dis World Health Organization. Coronavirus disease 2019, World Health Organisation Nov. Coronavirus -China SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China 2019-novel coronavirus infection in a three-month-old baby Novel coronavirus infection in hospitalized infants under 1 year of age in China First case of 2019 novel coronavirus infection in children in Shanghai First case of neonate infected with novel coronavirus pneumonia in China Frist case of severe childhood novel coronavirus pneumonia in China Innate and adaptive immune memory: an evolutionary continuum in the host's response to pathogens Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Undue reliance on I 2 in assessing heterogeneity may mislead Efficacy of mesenchymal stromal cells for fistula treatment of Crohn's disease: a systematic review and meta-analysis A basic introduction to fixed-effect and random-effects models for meta-analysis Analysis of CT features of 15 children with 2019 novel coronavirus infection Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China Clinical features and chest CT findings of coronavirus disease 2019 in infants and young children Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019 in Changsha Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Detectable SARS-CoV-2 Viral RNA in Feces of Three Children during Recovery Period of COVID-19 Pneumonia A retrospective study of the clinical characteristics of COVID-19 infection in 26 children Epidemiological and Clinical Characteristics of Children with Coronavirus Disease A comparative-descriptive analysis of clinical characteristics in 2019-Coronavirus-infected children and adults Detection of Covid-19 in children in early A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults Novel coronavirus infection in newborn babies aged <28 days in China High-Resolution Computed Tomography Manifestations of 5 Pediatric Patients With 2019 Novel Coronavirus Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China COVID-19 infection in Iranian children: a case series of 9 patients Chest computed tomography in children with COVID-19 respiratory infection Coronavirus Disease 2019 in Children-United States Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children Radiographic and Clinical Features of Children With Coronavirus Disease (COVID-19) Pneumonia Coronavirus Disease-19 Among Children Outside Wuhan Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study The different clinical characteristics of corona virus disease cases between children and their families in China-the character of children with COVID-19 Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia Clinical Characteristics of Children with Coronavirus Disease Novel coronavirus infection in children outside of Wuhan, China Clinical characteristics of a case series of children with coronavirus disease 2019 Clinical characteristics of COVID-19 in children compared with adults in Shandong Province Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019 Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias GRADE: an emerging consensus on rating quality of evidence and strength of recommendations A comparative-descriptive analysis of clinical characteristics in 2019-Coronavirus-infected children and adults Severe and fatal forms of COVID-19 in children Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and meta-analysis Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series